Neurocrine Biosciences (NBIX)
(Real Time Quote from BATS)
$117.66 USD
-0.69 (-0.58%)
Updated Sep 23, 2024 03:55 PM ET
After-Market: $117.74 +0.08 (0.07%) 4:14 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 10/29/24 |
---|---|
Current Quarter | 1.48 |
EPS Last Quarter | 0.63 |
Last EPS Surprise | -45.22% |
ABR | 1.38 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 4.19 |
Next Year | 7.07 |
EPS (TTM) | 3.31 |
P/E (F1) | 28.22 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 602.73M | 626.61M | 2.33B | 2.74B |
# of Estimates | 10 | 10 | 10 | 10 |
High Estimate | 623.00M | 645.00M | 2.37B | 2.86B |
Low Estimate | 593.20M | 608.00M | 2.31B | 2.61B |
Year ago Sales | 498.80M | 515.20M | 1.89B | 2.33B |
Year over Year Growth Est. | 20.84% | 21.62% | 23.71% | 17.38% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.48 | 1.61 | 4.19 | 7.07 |
# of Estimates | 10 | 8 | 8 | 10 |
Most Recent Consensus | 1.54 | 1.61 | 4.30 | 7.47 |
High Estimate | 1.76 | 1.84 | 4.65 | 8.45 |
Low Estimate | 1.21 | 1.35 | 3.68 | 5.37 |
Year ago EPS | 0.82 | 1.44 | 2.47 | 4.19 |
Year over Year Growth Est. | 80.49% | 11.81% | 69.64% | 68.64% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 7 | 6 | 3 | 7 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 2 | 5 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.48 | 1.61 | 4.19 | 7.07 |
7 Days Ago | 1.48 | 1.61 | 4.19 | 7.07 |
30 Days Ago | 1.48 | 1.61 | 4.19 | 7.07 |
60 Days Ago | 1.31 | 1.37 | 4.22 | 6.73 |
90 Days Ago | 1.30 | 1.31 | 4.03 | 6.69 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.48 | 1.61 | 4.19 | 7.07 |
Zacks Consensus Estimate | 1.48 | 1.61 | 4.19 | 7.07 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.63 | 0.42 | 1.44 | 0.82 | NA |
Estimate | 1.15 | 1.04 | 1.13 | 0.91 | NA |
Difference | -0.52 | -0.62 | 0.31 | -0.09 | -0.23 |
Surprise | -45.22% | -59.62% | 27.43% | -9.89% | -21.83% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more